Cargando…

Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines

Multi-drug resistance (MDR) of cancer cells severely limits therapeutic outcomes. A proposed mechanism for MDR involves the efflux of anti-cancer drugs from cancer cells, primarily mediated by ATP-binding cassette (ABC) membrane transporters including P-glycoprotein. This article reviews the recent...

Descripción completa

Detalles Bibliográficos
Autores principales: Chai, Stella, To, Kenneth KW, Lin, Ge
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920269/
https://www.ncbi.nlm.nih.gov/pubmed/20653978
http://dx.doi.org/10.1186/1749-8546-5-26
_version_ 1782185261194543104
author Chai, Stella
To, Kenneth KW
Lin, Ge
author_facet Chai, Stella
To, Kenneth KW
Lin, Ge
author_sort Chai, Stella
collection PubMed
description Multi-drug resistance (MDR) of cancer cells severely limits therapeutic outcomes. A proposed mechanism for MDR involves the efflux of anti-cancer drugs from cancer cells, primarily mediated by ATP-binding cassette (ABC) membrane transporters including P-glycoprotein. This article reviews the recent progress of using active ingredients, extracts and formulae from Chinese medicine (CM) in circumventing ABC transporters-mediated MDR. Among the ABC transporters, Pgp is the most extensively studied for its role in MDR reversal effects. While other MDR reversal mechanisms remain unclear, Pgp inhibition is a criterion for further mechanistic study. More mechanistic studies are needed to fully establish the pharmacological effects of potential MDR reversing agents.
format Text
id pubmed-2920269
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29202692010-08-12 Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines Chai, Stella To, Kenneth KW Lin, Ge Chin Med Review Multi-drug resistance (MDR) of cancer cells severely limits therapeutic outcomes. A proposed mechanism for MDR involves the efflux of anti-cancer drugs from cancer cells, primarily mediated by ATP-binding cassette (ABC) membrane transporters including P-glycoprotein. This article reviews the recent progress of using active ingredients, extracts and formulae from Chinese medicine (CM) in circumventing ABC transporters-mediated MDR. Among the ABC transporters, Pgp is the most extensively studied for its role in MDR reversal effects. While other MDR reversal mechanisms remain unclear, Pgp inhibition is a criterion for further mechanistic study. More mechanistic studies are needed to fully establish the pharmacological effects of potential MDR reversing agents. BioMed Central 2010-07-25 /pmc/articles/PMC2920269/ /pubmed/20653978 http://dx.doi.org/10.1186/1749-8546-5-26 Text en Copyright ©2010 Chai et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Review
Chai, Stella
To, Kenneth KW
Lin, Ge
Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines
title Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines
title_full Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines
title_fullStr Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines
title_full_unstemmed Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines
title_short Circumvention of multi-drug resistance of cancer cells by Chinese herbal medicines
title_sort circumvention of multi-drug resistance of cancer cells by chinese herbal medicines
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2920269/
https://www.ncbi.nlm.nih.gov/pubmed/20653978
http://dx.doi.org/10.1186/1749-8546-5-26
work_keys_str_mv AT chaistella circumventionofmultidrugresistanceofcancercellsbychineseherbalmedicines
AT tokennethkw circumventionofmultidrugresistanceofcancercellsbychineseherbalmedicines
AT linge circumventionofmultidrugresistanceofcancercellsbychineseherbalmedicines